Researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease. The study found phenylacetylglutamine (PAG), produced by gut bacteria ...

Nearly half of all adults in the U.S. have high blood pressure, or hypertension, according to the CDC. One of the most common ...

Please provide your email address to receive an email when new articles are posted on . Taking beta blockers may raise mortality risk for HSCT recipients due to suppression of signals from nerves that ...

Recent clinical studies have suggested that phenylacetylglutamine (PAGln), a novel gut microbial metabolite, can mechanistically modulate patients' risk of developing cardiovascular disease (CVD) and ...

T cells that are chronically stimulated in viral infection or cancer enter a dysfunctional state known as T-cell exhaustion. Sympathetic nerves in tissues and tumours drive T-cell exhaustion through ...

Brain metastases and anticoagulant therapy: Safety and outcome in a real-world study. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text ...

In a recent study, beta blockers appeared to significantly lower both the annualized risk for conversion from presymptomatic to symptomatic Huntington’s disease (HD) and the rate of worsening among ...

None of the current superresolution microscopy techniques can reliably image the changes in endogenous protein nanoclustering dynamics associated with specific conformations in live cells.

Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC). Effect of cytoreductive nephrectomy on the efficacy of immunotherapy in metastatic ...